Director, Oncology Market Access Marketing
AbbVie
Summary
The Director of Oncology US Market Access Marketing will lead market access marketing strategy for VENCLEXTA (venetoclax) at AbbVie. VENCLEXTA is an oral oncolytic jointly commercialized by AbbVie and Genentech, an external partner organization. It is approved in two hematology indications: Chronic Lymphocytic Leukemia (CLL) and Acute Myeloid Leukemia (AML).
Job description
The Director will lead market access strategy and manage two direct reports. The role is accountable for contracting and customer engagement strategy across all payer channels (e.g., Commercial, Medicare, Medicaid, VA, etc.) and GPO/Community Oncology. The Director will lead strategic alignment with the Market Access field and orchestrate strategy, communication, and alignment across US Market Access Channel and Policy teams.
As the overarching Market Access Marketing subject matter expert for the VENCLEXTA Integrated Brand Teams, the Director will develop Market Access strategies with stakeholders in the Oncology commercial organization and US Medical Affairs. The Director will manage Market Access interactions and collaborative relationships with relevant Genentech staff, including Joint Commercialization Council decision-making with AbbVie and Genentech senior leaders.
The role will also lead the Market Access components of key accounts strategy development across functions within AbbVie and Genentech, translating VENCLEXTA's unique clinical and economic profile into a value story and resources that resonate across payer, provider institution, government, and community segments. The Director will leverage data, analytics, and a strong strategic mindset in all aspects of running the marketing component of the business, provide positive leadership, and influence cultural alignment with US Market Access's Ambitious Cultural Vision.
Key Responsibilities Include:
- Provide leadership and direction for Marketing vision, strategies, plans and resource investment for VENCLEXTA.
- Encompass a "One for All AbbVie" mindset and perspective in all strategies.
- Act as Market Access primary contact for Oncology leadership relative to Plan, LBE, LRP and other financial & planning processes.
- Set tone and priorities for scale and scope of accountability.
- Influence and persuade across multiple external and internal stakeholders (both US and Global) and partners.
- Infuse AbbVie Ways of Working and Talent Philosophy in day-to-day leadership and overall management of the business.
- Uses coaching effectively and efficiently to influence cross-functional partners.
- Determine appropriate project actions and oversee execution, tracking, and monitoring.
- Employ scenario planning, segmentation, positioning, innovation, creative development, and investment optimization as needed.
- Build a value proposition for each stakeholder by articulating the business strategy and economic choices relevant to that stakeholder.
Requirements
- Bachelor's Degree required
- Proven marketing experience required
- 10+ years of pharmaceutical experience required
- Cross-functional experience valued, including field sales, finance, market analytics, and brand marketing
- Positive, solutions-oriented attitude required
- Market access or CLL/AML/MDS/Hematology experience preferred
- Commercialization of oral oncolytics preferred
- Companion diagnostics experience preferred
- Experience in external collaboration preferred
Benefits
- Paid time off
- Medical, Dental & Vision Insurance
- 401(k)
- Long-term incentive programs
Company overview
AbbVie is a global biopharmaceutical company that discovers, develops, and markets advanced therapies for some of the world's most complex and serious diseases. Founded in 2013 as a spin-off from Abbott Laboratories, AbbVie has established itself as a leader in immunology, oncology, neuroscience, eye care, and virology. The company's flagship product, Humira (adalimumab), was one of the world's top-selling drugs for treating autoimmune conditions like rheumatoid arthritis and Crohn's disease. AbbVie maintains a robust pipeline of innovative medicines and has expanded its portfolio through strategic acquisitions, including Allergan in 2020. With research facilities across the United States and globally, AbbVie focuses on advancing science to improve patient outcomes while maintaining strong commercial operations worldwide. The company operates with a patient-centric approach and invests significantly in research and development to address unmet medical needs across multiple therapeutic areas.